Literature DB >> 21881934

Gemfibrozil hepatotoxicity: a case report.

Patricia Domínguez Tordera1, José Francisco Comellas Alabern, Félix Ronda Rivero.   

Abstract

CASE DESCRIPTION: A 55-year-old woman was admitted to our hospital for management of thoracic trauma and bone fractures. One month after admission she started to receive gemfibrozil for hypertriglyceridemia. In the second month of admission, the patient complained of nausea and malaise. Laboratory value showed an acute hepatitis with raised AST, ALT. The abdominal ultrasound scan was normal, and viral serologic tests were negative. Gemfibrozil was discontinued and in a few days AST and ALT levels returned to normal.
CONCLUSION: Gemfibrozil-induced hepatitis is a rare event but should be considered in the differential diagnoses of hepatitis in which no other obvious alternative cause is found.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21881934     DOI: 10.1007/s11096-011-9550-x

Source DB:  PubMed          Journal:  Int J Clin Pharm


  7 in total

Review 1.  Special considerations in interpreting liver function tests.

Authors:  D E Johnston
Journal:  Am Fam Physician       Date:  1999-04-15       Impact factor: 3.292

Review 2.  Drug-related hepatotoxicity.

Authors:  Victor J Navarro; John R Senior
Journal:  N Engl J Med       Date:  2006-02-16       Impact factor: 91.245

3.  [Acute hepatitis caused by gemfibrozil].

Authors:  M Bustamante Balén; G Plumé Gimeno; I Bau González; J Berenguer Lapuerta
Journal:  Gastroenterol Hepatol       Date:  1998-10       Impact factor: 2.102

Review 4.  Drug-induced liver disease.

Authors:  H J Zimmerman
Journal:  Clin Liver Dis       Date:  2000-02       Impact factor: 6.126

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  Fenofibrate-induced acute cholestatic hepatitis.

Authors:  Chiu-Yung Ho; Tzong-Haur Kuo; Tseng-Shing Chen; Shyh-Haw Tsay; Full-Young Chang; Shou-Dong Lee
Journal:  J Chin Med Assoc       Date:  2004-05       Impact factor: 2.743

Review 7.  Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring.

Authors:  D R Dufour; J A Lott; F S Nolte; D R Gretch; R S Koff; L B Seeff
Journal:  Clin Chem       Date:  2000-12       Impact factor: 8.327

  7 in total
  1 in total

1.  Literature review of the clinical characteristics of metformin-induced hepatotoxicity.

Authors:  Chunjiang Wang; Hongyi Deng; Yunfei Xu; Ying Liu
Journal:  Front Pharmacol       Date:  2022-09-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.